Author

Sunyana Gadal

Memorial Sloan Kettering Cancer CenterORCID 0000-0003-3073-4067Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Elisa de StanchinaiD· 2 shared Malvika SharmaiD· 2 shared Neal X. RoseniD· 2 shared Qing ChangiD· 2 shared Afşar BarlasiD· 1 shared Alexander Edward Dela Cruz DriloniD· 1 shared Corina AmoriD· 1 shared Douglas Warner· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Elisa de StanchinaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJul 21, 2025

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Jacob A. Boyer, Ezra Y. Rosen, Malvika Sharma…·Neal X. Rosen

This paper identifies eIF4A as a key regulator of ER translation in breast cancer and shows that inhibiting eIF4A, either alone or with fulvestrant, suppresses ER expression and tumor growth in advanced ER+ breast cancer.

16 citationstop 1%

humanproteomics

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedFeb 24, 2025

Tumorigenesis driven by the BRAF V600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion

Sunyana Gadal, Jacob A. Boyer, Simon F. Roy…·Neal X. Rosen

This study shows that BRAFV600E mutations inhibit cell migration and invasion through feedback inhibition of RAC1, requiring secondary mutations to overcome this block and enable tumorigenesis.

7 citations

humanDNA methylation

𝕏 PostBluesky